Sarepta 治療公司
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership24,176 shares
Latest Disclosed Value $ 909,017
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.50% increase in ownership of SRPT / Sarepta Therapeutics, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 24,176 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $909,018 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 24,056 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 0.50% during the quarter. The current value of the position is $380,772 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 24,176 120 0.50 909 -64.59 0.0120
2025-04-25 2025-02-28 NP SAREPTA THERAPEUTICS EC US8036071004 24,056 602 2.57 2,568 -17.91 0.0346
2025-01-27 2024-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 23,454 168 0.72 3,127 -1.08 0.0424
2024-10-29 2024-08-31 NP SAREPTA THERAPEUTICS EC US8036071004 23,286 228 0.99 3,162 5.58 0.0468
2024-07-26 2024-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 23,058 300 1.32 2,994 2.89 0.0474
2024-04-24 2024-02-29 NP SAREPTA THERAPEUTICS EC US8036071004 22,758 372 1.66 2,911 59.98 0.0486
2024-01-24 2023-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 22,386 36 0.16 1,820 -32.73 0.0349
2023-10-27 2023-08-31 NP SAREPTA THERAPEUTICS EC US8036071004 22,350 360 1.64 2,705 -0.48 0.0528
2023-07-26 2023-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 21,990 72 0.33 2,718 1.53 0.0586
2023-04-27 2023-02-28 NP SAREPTA THERAPEUTICS EC US8036071004 21,918 540 2.53 2,677 1.94 0.0655
2023-01-26 2022-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 21,378 564 2.71 2,625 15.33 0.0656
2022-10-26 2022-08-31 NP SAREPTA THERAPEUTICS EC US8036071004 20,814 -1,407 -6.33 2,277 40.67 0.0569
2022-07-29 2022-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 22,221 676 3.14 1,618 -1.94 0.0412
2022-04-28 2022-02-28 NP SAREPTA THERAPEUTICS EC US8036071004 21,545 14,882 223.35 1,651 206.69 0.0382
2022-01-25 2021-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 6,663 172 2.65 538 6.11 0.0113
2021-10-26 2021-08-31 NP SAREPTA THERAPEUTICS EC US8036071004 6,491 -9,172 -58.56 507 -57.18 0.0111
2021-07-22 2021-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 15,663 60 0.38 1,185 -12.81 0.0295
2021-04-23 2021-02-28 NP SAREPTA THERAPEUTICS EC US8036071004 15,603 -2,516 -13.89 1,358 -46.79 0.0354
2021-01-20 2020-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 18,119 3,369 22.84 2,552 18.20 0.0763
2020-10-16 2020-08-31 NP SAREPTA THERAPEUTICS EC US8036071004 14,750 260 1.79 2,160 -2.13 0.0667
2020-07-20 2020-05-31 NP SAREPTA THERAPEUTICS EC US8036071004 14,490 1,786 14.06 2,206 51.72 0.0861
2020-04-24 2020-02-29 NP SAREPTA THERAPEUTICS EC US8036071004 12,704 1,558 13.98 1,454 16.04 0.0649
2020-01-16 2019-11-30 NP SAREPTA THERAPEUTICS EC US8036071004 11,146 11,146 1,254 0.0569
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.